Aquestive Therapeutics, Inc. (AQST) insider trading

By person

15 insiders · 19 transactions

4.0×

Daniel Barber holds only 4.0 times base salary in stock. $2.65M of shares against $659.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Barber last reported holding, valued at $4.22, the price Common Stock was last bought or sold at on the open market here, on 15 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Daniel Barber

President and CEO

—

$1.33M (8)

−$1.33M

627,317

0.4998%

$2.65M

−24.1%

A Ernest Toth Jr

Chief Financial Officer

—

$243.09K (1)

−$243.09K

283,460

0.2258%

$1.20M

+14.2%

Cassie Jung

Chief Operating Officer

—

$191.09K (1)

−$191.09K

208,833

0.1664%

$882.11K

−11.2%

Lori J Braender

Corporate Secretary

—

$167.35K (1)

−$167.35K

231,042

0.1841%

$975.92K

−26.2%

Julie Krop

Director

—

$125.39K (1) scheduled

−$125.39K

0.0000%

$0.00

—

Peter E. Boyd

Chief People Officer

—

$124.41K (1)

−$124.41K

284,024

0.2263%

$1.20M

+19.5%

Sherry Korczynski

Chief Commercial Officer

—

$111.36K (2)

−$111.36K

235,689

0.1878%

$995.55K

+214.3%

Melina Cioffi

SVP, Regulatory Affairs

—

$105.62K (1)

−$105.62K

273,200

0.2177%

$1.15M

+49.9%

Stephen Wargacki

Chief Science Officer

—

343,552

0.2737%

$1.45M

+31.4%

Carl N Kraus

Chief Medical Officer

—

282,475

0.2251%

$1.19M

+12.2%

Douglas K Bratton

10% owner

—

199,841

0.1592%

$844.13K

−16.7%

John Cochran

Director

—

161,715

0.1288%

$683.08K

+62.6%

Thomas A. Zalewski

Chief Legal Officer

—

100,000

0.0797%

$422.40K

—

Matthew W. Davis

Chief Development Officer

—

100,000

0.0797%

$422.40K

—

Matthew J. Greenhawt

Chief Medical Officer

—

75,000

0.0598%

$316.80K

—

Aquestive Therapeutics, Inc.

What the insiders did Net selling

By person